A Clinical Trial of Lurasidone in Treatment of Schizophrenia
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, double-dummy, parallel- controlled, adjustable dose,
non-inferiority and multicentre study designed to evaluate the efficacy and safety of
lurasidone on schizophrenia for 6 weeks treatment, and to compare with risperidone.